The commercial decalcified bone scaffold combined with the patient's autologous bone marrow mesenchymal stem cells was used for in vitro culture to form tissue-engineered bone, and the effect of this tissue-engineered bone in early non-traumatic femoral head necrosis was explored.
Age range
20 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
To verify the effectiveness of tissue-engineered bone in the treatment of early femoral head necrosis
Timeframe: 1 month, 2 months, 3 months, 6 months and one year after the operation
To verify the effectiveness of tissue-engineered bone in the treatment of early femoral head necrosis
Timeframe: Before the operation, 1 month, 6 months and 1 year after the operation
To verify the effectiveness of tissue-engineered bone in the treatment of early femoral head necrosis
Timeframe: Before the operation, 6 months after the operation and 1 year after the operation